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The involvement of children in research raises particular ethical 
concerns because of their reduced autonomy and their 
incompetency to give informed consent. Such concems would not 
be answered simply by restricting participation in research to 
persons who are competent to consent, for the conduct of research 
involving children is necessary not only to develop ffew 
treatment(s) .. . but also to protect children from accepted though 
unvalidated practices that may be harmful to them. 
- Report and Recommendations on 
Research Involving Children 
The citation above identifies the subject of this research paper-
should children participate in therapeutic research even if it involves 
some risk to them? What special conditions must be met if therapeutic 
research with measurable risk is permitted? What does the government 
say? What does Roman Catholic theology/ethics offer on this matter 
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of subjecting the vulnerable to risk while trying to solve the mystery of 
their specific disease? 
In order to attempt an answer to these questions I will 1) review 
the history of human experimentation in children; 2) review the 
development and, finally, the execution of federal legislation in the 
United States that address children and research, namely the National 
Commission's Report and Recommendations on Research Involving 
Children; 3) discuss the Roman Catholic position including the 
theological underpinnings regarding the use of children as research 
subjects. The paper will also include a discussion of some of the 
critical disputes during the Commission's deliberations including 
defining minimal risk and the wisdom of subjecting children to 
nontherapeutic research. Finally, I will present a case study based on 
the research of Duchenne Muscular Dystrophy illustrating the 
importance and relevance of the Commission's work in the 1970s to the 
regulation of research today. Special emphasis will be placed on 
Recommendations #2 and #4 of the Commission since these speak 
directly to the case to be studied. 
Research is a formal investigation designed to develop or 
contribute to generalizable knowledge, and is generally defined by the 
subject. (National Commission, 1977, xx) Therapeutic research 
involves studies that are designed to aid subjects that have a specific 
disease. Nontherapeutic research is defined as research that may not 
help individual patients but will add to generalizable knowledge. 
Research conducted on normal subjects is also, for the most part, 
nontherapeutic. 
Physician as Both Clinician and Researcher 
I would like to say a word about the continuing problem of 
unbiased researchers performing appropriate research on appropriate 
subjects, including vulnerable populations. Traditionally, there has 
been a tension between the physician as clinician and the physician as 
researcher, since the goals of each role (!.iffer. Research is designed 
primarily to generate or validate new knowledge while clinical practice 
is geared toward enhancing the patient's well being. For example, a 
clinician might want to treat a young patient with acute leukemia with 
an experimental chemotherapeutic agent that had great promise in 
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combating the loss of normal red blood cells and save the child's life. 
That same physician, however, as researcher, is probably focused on the 
results of the trial on the whole population of leukemic children when 
assessing a research protocol for that drug therapy. This tension was 
brought to national prominence in the National Surgical Adjuvant 
Breast Study in which data were fraudulently entered, and potential 
subjects were coerced to join the study by physicians who admittedly 
used their influence to obtain informed consent. (Mueller, 1995, 2404). 
This duality of responsibility as caregiver and scientist is, in my 
view, a key element in any attempt to understand the origin and 
continuing need for vigilance within the medical community about 
human subjects and research. This understanding is essential so that 
the self-interest and likely economic gains by the scientist of any 
medical breakthroughs are not allowed to endanger or compromise the 
clinician's duties or the vulnerable patient's rights. 
Protection of Human Subjects 
The codified history of protection for human subjects is a little 
over fifty years old. Since the medical atrocities in Nazi Germany 
during World War II, there have been progressively stringent guidelines 
and laws governing experimental research in the United States and 
throughout the world. The Nuremburg Code, the first of these 
guidelines, was the cornerstone for "informed, uncoerced, voluntary 
consent of the subject." (Grodin, 1988, 1391) However, the Nuremburg 
cede excluded children by its '.'no consent-no research" language. 
(Kopelman, Loretta, in Reich, 1995, 361) Not until 1964, in the 
Helsinki Declaration were children recognized as acceptable subjects. 
The Helsinki Declaration restricted the use of children as research 
subjects to therapeutic research only, and required protection and 
surrogate decision-making if children were to be used for research. It 
was after this, during the 1970s, that guidelines were developed in the 
United States for children as research subjects. 
At the level of ethical principles, guidelines developed in the 
United States to protect children as research subjects employed a 
risklbenefit approach. Michael Grodin, M.D., Director of Medical 
Ethics at Boston University's School of Medicine and Public Health, 
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characterizes the risklbenefit approach as one that allows research with 
children if it holds out direct benefit to them or does not place them at 
unwarranted risk of harm, discomfort or inconvenience. (Grodin, 1994, 
31) These risklbenefit approaches balance the social utility of research 
with respect for and protection of children. The greater the risk of the 
research protocol, the more rigorous and elaborate the procedural 
protection for the children and consent requirements for the child and 
his or her parent/guardian. (Kopelman, Loretta, in Reich, 1995, 362) 
History of Children and Research 
The history of children as research subjects is really a subset of 
the history of children in general. Children were considered chattel of 
their fathers until the mid-seventh century in England. In other words, 
they were considered property without rights. In fact, children were not 
considered individuals with specific needs nor were they cared for in 
earnest until the seventeenth century. Pediatric care at that time was 
considered beneath the dignity of physicians. (Grodin, 1988, 1389) 
With the establishment of the American Society for the 
Prevention of Cruelty to Children by New York reformer Eldridge 
Thomas Gerry in 1874, mortality rates in children began to decrease, 
and pediatrics began in earnest. (Hawes and Hiner in Reich, 1995,353) 
Hawes and Hiner summarize: "By the late 20th century virtually all 
advanced industrial countries ... had made significant strides in reducing 
some of the threats to children's health and well-being." (Hawes and 
Hiner in Reich, 1995, 354) However, as children became healthier, 
they were used increasingly in research to try to remedy childhood 
illnesses with little or no regulation, control, safety studies, efficacy, or 
ethics. 
Exposure of the now famous Willowbrook incident was, for 
" some, the seminal event in the history of medical research on children. 
Willowbrook alerted physicians, ethicists, politicians, and the general 
public of the United States that something has to be done to protect 
vulnerable children from abuses by medical researchers. The 
Willowbrook State School on Staten Island, New York, was an 
institution that cared for severely mentally handicapped children. In 
fact, almost 80% ofthe children had IQs ofless than 20. (Beauchamp 
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and Childress, 1983, 317) The population of children grew from 200 
in the late 1940s to over 6,000 in 1963. These patients had serious 
disabilities including limited toilet training abilities. And as the 
population grew, so did the incidence of hepatitis. 
The bacteria that causes infectious hepatitis can be found in the 
gastrointestinal tract, and is transmitted by contaminated hand -to-
mouth contact. It was commonplace for newly admitted patients at 
Willowbrook to become infected with hepatitis within the first six to 
twelve months of their institutionalization. However, it should be 
noted that the strain of hepatitis contracted was described as mild when 
seen in children ages three to ten. (Beauchamp and Childress, 1983, 
317) 
In an attempt to study the disease process and develop more 
effective agents to abate the spread ofthe hepatitis, Dr. Saul Krugman 
and his associates conducted a number of studies beginning in the 
1950s on Willowbrook patients. Some of the children in the study 
group of about 800 (out of 10,000 admissions to Willowbrook during 
that time frame) were artificially exposed to the Willowbrook strain of 
infectious hepatitis. The childrens' parents had given their consent. In 
fact, initially parents were either interviewed personally or by letter 
about the progress of their children. Wards of the state or children 
without parents were not included in the studies. It was considered a 
direct benefit of the study that the children who were exposed to 
hepatitis frequently developed immunity from hepatitis itself once they 
had contracted the mild "Willowbrook" form of the disease. The 
studies were reviewed and sanctioned by the regulatory agencies at the 
time. (Beauchamp and Childress, 1983, 318) 
Response to Abuse of Subjects: 
The Belmont Report and the National Commission 
Ten years after the Beecher article, Congress passed PL 93-348, 
creating the National Commission for the Protection of Human 
Subjects of Biomedical and Behavioral Research. Soon after, the 
Commission released the Belmont Report which supplied the 
foundational, ethical principles for all research on human subjects. 
These principles included respect for persons, beneficence and justice. 
(Belmont Report, 1978,4) 
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Respect for persons requires that the choices of autonomous 
individuals be respected. But some Commissioners like Robert Cooke 
(then President of Medical College of Pennsylvania) argued that the 
protection of individual autonomy via informed consent was not the 
vital issue in children since they are generally not autonomous until late 
childhood or adolescence. The real issue, he claimed, was the 
protection of the vulnerable - including children. (McCartney, 1978, 
27) Consequently, the "dual aspect of respect for persons, that is 
preservation of individual autonomy, and protection of the defenseless" 
were both developed by the Commission in the Belmont Report. 
(McCartney, 1978, 27) That report states that respect for persons 
incorporates at least two basic ethical convictions: first, that individuals 
should be treated as autonomous agents, and second, that persons with 
diminished autonomy are entitled to protection. (Belmont Report, 1978, 
4) 
The National Commission discussed the issue of diminished 
autonomy and diminished capacity to consent - and the need to develop 
mechanisms to protect these vulnerable and/or nonautonomous 
populations like children. Cooke and Robert Turtle, a Washington, 
D.C. lawyer, argued for involvement of the entire family unit and the 
importance of parents in decision making for their children. They 
contended that the involvement of the whole family in the research 
project would provide a protective mechanism for the child-subject. 
Further, they argued that "only children from loving families should be 
allowed to participate in research." (McCartney, 1978, 27) The 
concerns of Cooke and Turtle were recognized by the Commission in 
the recommendations that require parents to be witness to specific 
research so that they could act on their child's behalf, if necessary. 
(McCartney, 1978, 27) 
Commissioner Patricia King, Georgetown University Law 
Center, argued for a "sliding scale from nonautonomy to full 
autonomy". (McCartney, 1978,27) Recognizing King's argument, the 
Commission required children over age seven to give their own assent 
to participation in research and recognized the objection of a child to 
participation as binding "unless the intervention holds out a prospect of 
direct benefit to the child and is available only in the context of 
research. (McCartney, 1978,27) 
The Commission was careful about the language it used to 
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describe infonned consent. The Commissioners opted to use the word 
"pennission" to describe parental consent because it clarified that the 
parents were acting as the "loving protectors and providers of their 
children" not as agents offering proxy consent (consent on behalf of 
someone else). (McCartney, 1978, 27) This step was taken to avoid 
difficulties that had arisen in the past when parents were viewed as 
proxies for their children. (McCartney, 1978, 27) 
Beneficence, the second principle, requires both the provision 
of benefit and the avoidance of harm. This principle is applied to 
research in several ways. The promotion of health is a benefit of 
research because it improves methods to prevent or treat disease or an 
abnonnal condition and serves to foster optimal growth and 
development. In addition, children can benefit from research that looks 
at the nature of childhood disorders, some precursors of adult disorders, 
and the nonnal physiological, psychological and social development of 
children. Children may benefit from this research as individuals or as 
a class. (National Commission, 1977, 123) 
It is this ethical principle that resulted in the most difficult 
decision making for the Commission. Basic differences and 
disagreements among the Commissioners arose about the importance 
and scope of this principle. In particular, the difference between 
therapeutic (holds the prospect of directly benefitting the patient) and 
nontherapeutic (does not hold the prospect of directly benefitting the 
patient) research and its justification with children was a central issue 
for the Commissioners. (McCartney, 1978, 28) 
The imperative for researchers to "do no harm", the other side 
of beneficence, is equally important in the evaluation of research on 
children. Avoidance of harm or nonmaleficence requires that "risk to 
human subjects be reduced or eliminated in the actual conduct of 
research". Avoidance of harm may serve as justification for research 
designs that evaluate the efficacy and safety of Procedures already in 
standard practice. (National Commission, 1977, 124) In addition, 
research might be justified because it avoids harm that might result 
from the application of inappropriate routine practices. For example, 
a standard medical procedure might be dangerous if not adapted for the 
special physiology of children and infants (i .e. , oxygen levels, fluid 
requirements). 
The third principle of the Belmont Report is justice or a fair 
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distribution of the burdens and benefits in a given population. In a 
research context, this principle requires that the burdens of being 
involved in research are fairly distributed and that the benefits produced 
by the research are fairly allocated. 
Two dangers of injustice mentioned in the National 
Commission's Report and Recommendations on Research Involving 
Children are: overutilization of some groups of children because they 
are readily available (i.e., orphans); and the danger of using children too 
soon in certain studies in which animal studies, older children, or adults 
could be used with less risk and better allocation of that risk. (National 
Commission, 1977, 132) 
The actual implementation of these principles procedurally 
included the establishment of the following: 1) evidence of informed 
consent or surrogate's consent prior to the onset of research protocols; 
2) measurement of risk and assessment of benefit for protocols; and 3) 
consideration of fair procedures and outcomes in the selection of 
research subjects. 
Peer review boards or what became known as Institutional 
Review Boards (IRBs) were established as an outcome of the Belmont 
Report. These bodies were charged with ensuring that research is 
conducted according to the principles set down by the report in each 
and every federally-funded research institution in the country. 
Some critics consider the peer review process developed for 
current IRBs to be faulty because the system is built on a paternalistic 
rather than an autonomy model. In other words, the IRBs make 
decisions of risk and benefits to the subjects independent of the 
subjects' consent and before the research has begun. IRBs, therefore, 
are "frontloaded". The local board is looking at the plans for the 
research and the intention of the researcher which some critics consider 
a loophole in the process. Arthur Caplan, Ph.D., Director of Bioethics 
at the University of Pennsylvania, in discussing the pros and cons of the 
current system of regulation, notes that there might be reason to revise 
the process so that a procedure or protocol can be assessed while it is 
in progress, as its data is coming in to see what is happening and what 
patient outcomes are developing. Says Caplan, "Right now, IRBs don't 
look at corpses." (Caplan, 1995) 
In any case, it is the principles developed in the Belmont Report 
that provided the essential underpinnings for ethical research practices 
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in children in the United States. In 1978, using the three principles 
developed in the Report, the National Commission issued actual 
regulations for children in a document entitled Report and 
Recommendations: Research Involving Children. The Commission set 
out to basically answer two questions: 1) under what conditions is the 
participation of children in research ethically acceptable? and, 2) under 
what conditions may such participation be authorized by the subjects 
and their parents? (National Commission, 1977, iii) 
Commission Recommendations 
and Deliberations 
The National Commission deliberations concluded in the 
issuance of ten recommendations designed to protect children who 
might be involved in medical research (See Appendix for text of the ten 
recommendations.). The Commissioners spent a good deal of time 
determining the degree and circumstances in which children could be 
subjected to research protocols. The debates included focus on the 
principles established by the Belmont Report, namely 1) respect for 
persons, especially protection of vulnerable populations; 2) 
beneficence; and 3) justice. (McCartney, 1978) 
Informed consent is the practical outcome or guideline designed 
to assUre respect for persons. It is, of course, the standard for research 
protocols involving adults. But the doctrine of informed consent is not 
applicable to those who cannot decide due to their age (or diminished 
capacity in the case of adults). So, the protection of the vulnerable and 
the preservation of individual autonomy were addressed by the 
Commission in their insistence on parental pennission prior to research 
participation by children and assent of children to the degree their age 
allows. 
The second principle from the Belmont Report, beneficence, 
was considered the most difficult to apply to children and the most 
problematic to the Commission. (McCartney, 1978, 27) The words 
"therapeutic" and "nontherapeutic" were not used by the Commission. 
Rather, they used language that related to the benefit to the child -
"direct" or "indirect". Requirements for conducting beneficial research 
included stipulations that the research risks must be justified by the 
anticipated benefits, the anticipated benefits relative to the risk must be 
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as favorable to the children as other approaches, and there must be 
assent of the children and permission from the parents. 
Minimal Risk 
Minimal risk can be considered a part of the beneficence 
principle because this principle supports the need for a minimum 
standard to determine the safety of the research to the child subject. In 
other words, it was relatively easy for the Commissioners to decide to 
allow research that would help a child (therapeutic research). But it 
was not easy to determine how much risk to allow within the research 
protocol and still maintain the benefit originally intended. Benefit must 
outweigh risk to protect the subject. So determining minimal risk was 
essential. 
The question of minimal risk was discussed vigorously by the 
Commission. The discussion ranged from Commissioners arguing for 
minimal risk to mean a "mere inconvenience" to those arguing for a 
definition that defines minimal as "that which does not involve any 
risks to children greater than those normally encountered in their daily 
lives." (McCartney, 1978, 29) Robert E. Cooke urged the use of 
minimal risk as the barrier to allowable research. However, he did not 
believe that minimal could be defined as anything "normally 
encountered in daily life" because it did not allow for variations in 
circumstances. So, for example, normal for a healthy child would be 
different than normal for a leukemic child. (McCartney, 1978, 29) 
Cooke did not prevail, and the Commission defined minimal 
risk in what many critics consider a narrow manner. Minimal risk is 
defined by the Commission as the "probability and magnitude of 
physical or psychological harm that is normally encountered in the daily 
lives, or in the routine medical or psychological examination, of healthy 
children." (National Commission, 1977, xx) Critics claim that the 
Commission did not adopt a definition broad enough for peer review 
boards to adapt their approval to different situations but instead created 
confusion for IRBs. (McCartney, 1978, 30) 
Research that was without benefit to the child and involved 
more than minimal risk was initially going to be banned by the 
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Commission. But the Commission was concerned that since they had 
such a narrow definition of minimal risk and had already adopted a 
national review board procedure to handle cases that did not apply to 
their definition, that they needed to offer some guidance so that an 
inordinate number of cases did not end up requiring national 
evaluation. 
Donald Seldin, professor of internal medicine at the University 
of Texas, argued for a recommendation that would allow research that 
carried a minor increase over minimal risk even without guarantee of 
direct benefit to the subject. Cooke argued against Seldin's 
recommendation because he was concerned that some children could 
be harmed "for the benefit of others." (McCartney, 1978, 30) The 
outcome was Recommendation #5, the most controversial of all the 
recommendations, which offers conditions in which research can be 
conducted on children even without direct benefit for the subject and 
with a "minor increase over minimal risk." Cooke, along with Turtle, 
cast dissenting votes. (McCartney, 1978, 30) 
The National Commission recommendations and subsequent 
federal regulations on minors issued in 1983 by the Department of 
Health and Human Services (DHHS) outlined categories of minimal 
risk for children to be used by the IRBs. The categories outlining 
minimal risk adopted by HHS were the same "sliding scale" categories 
offered by the National Commission. The four categories, moving from 
the least perilous risk to children to the most dangerous risk, include 
studies that 1) involve no more than minimum risk with the prospect of 
direct benefit to the child; 2) involve more than minimal risk with the 
benefit directly to the child; 3) involve more than minimum risk with no 
benefit to the child - but the possibility of generalizable knowledge; 
and 4) research designed to "lead to the understanding, prevention or 
alleviation of a serious problem." (Grodin, 1994, 123) 
The risklbenefit approach that weighs risk against gain rather 
than precluding any research with children involving risk has spawned 
many critics. Key terms used by the Commission are considered 
vaguely defined. Interpretations vary as to the acceptability of risks that 
could bring harm to children and the essential elements of a benefit are 
debatable. (Grodin, 1994, 124) Loretta Kopelman describes the 
problems created as "particularly difficult with the pivotal terms 
'minimal risk' and 'minor increase over minimal risk'." Problems 
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include: vagueness of the term minimal risk (What is the baseline for 
everyday hazards?); lack of guidance about the assessment of 
psychosocial risks such as labeling or invasion of privacy; and lack of 
definition of the upper limit of "minor risk over minimal" which makes 
it difficult for local boards (IRBs) to know what they can and cannot 
approve. (Kopelman in Reich, 1994, 362) 
Clearly, this is a serious problem for IRBs, ethicists, and 
researchers themselves. The policies that were established for children 
were intended to protect them and promote their well-being. However, 
critics say it is difficult to determine when research involving children 
can be permitted. On the one hand, if research is not conducted using 
children, then they will not benefit from the advances science makes 
possible. On the other hand, if children are used as experimental 
subjects, 'vulnerable individuals, who need protection, risk possible 
harm. The Commission's position and, consequently, the 
recommendatioris, are considered moderate. James McCartney, Ph.D., 
in reviewing the recommendations, says that moderation is not by 
accident but reflects the intention of the Commission to "go on record 
as emphasizing that scientific research is important and can in most 
cases be performed ethically." (McCartney, 1978, 31) 
The third area outlined by the Belmont Report is justice. When 
the National Commission dealt with this ethical principle, it required 
distributive justice. That is, the Commission required that children-
subjects be selected equitably among the possible research participants. 
Attention to this principle ensured that administrative ease and/or the 
availability of a population with certain conditions or socioeconomic 
characteristics would not unduly burden a given group. (See 
Recommendation #2, Appendix) The burdens and benefits were to be 
shared between all groups. (McCartney, 1978, 30) In addition to a 
specific mention in Recommendation #2, the commission reiterated this 
principle in Recommendations 9 and 10, which deal with specific 
vulnerable populations. (See Appendix) 
The principle of justice was one of the principles raised in 
relation to Recommendation #5, which has already been identified in 
this paper as the most problematic of the ten recommendations. Robert 
Turtle argued against the use of sick children for experiments that 
would require risk above the minimum. His concern is that a child 
"becomes accustomed to certain types of medical interventions because 
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of an illness, [but] it is unjust to utilize these techniques on the child in 
the context of research when there is little or no chance of benefitting 
that...child." (McCartney, 1978, 30). But the recommendation 
remained vague in its final form, and Turtle's objections were not 
heeded with specific language that might have protected sick children. 
Roman Catholic View on Human Life 
and Experimentation 
The ethical principles identified by the Belmont Report (and the 
recommendations that followed) are examples of one way that public 
policy is developed in the United States. Morality, or the rightness or 
wrongness of conduct, is both distinct from and related to public policy, 
argues moral theologian Richard McCormick. (McCormick, 1981, 72) 
These two concepts are related because public policy "has an inherently 
moral character due to its rootage in existential human ends (goods)." 
He adds: "The common good of all persons cannot be unrelated to what 
is judged to be promotive or destructive to the individual - in other 
words, judged to be moral or immoral." (McCormick, 1981, 72) 
While morality does not have to have religious roots, religious 
traditions, Christian or otherwise, have developed moral arguments 
based on their theological viewpoints. Roman Catholic and 
Reformation Protestant theological viewpoints obviously differ. It is 
important to consider briefly the distinction between those two views 
and some models of ethics in order to understand the arguments about 
research and children presented in this paper. 
Traditional Roman Catholic moral theology is grounded in 
natural law. Thomas Aquinas, in his development of natural law, 
argues that human beings are basically good because they were created 
in the image and likeness of God or Imago Dei. (Scanlon, 1995) 
Because of this likeness, Aquinas argues that women and men have the 
ability to reason by which they can discern what God wants. This view 
suggests that Christians find a common ethical wisdom and knowledge 
not just in the scriptures or in Jesus Christ but also in human nature and 
human reason. Further, insistence on the goodness of the natural and 
the human, with its corollary that grace builds on nature /and is not 
opposed to nature, stands as a hallmark of the Catholic theological 
tradition. (Curran, 1985,6) Thomas' view is considered an example of 
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a teleological model. That is, he views the ethical life in tenns of the 
goal or end to be achieved. (Curran, 1985, 5) The Roman Catholic 
world is a moral world where persons know the difference between 
right and wrong by virtue of natural law. 
In contrast, the characteristic Protestant view of the world and 
personhood is grounded traditionally in Augustinian theology. That is, 
persons are flawed by original sin and this penneates both the natural 
and the supernatural. Therefore, refonn by humankind would always 
be suspect and should not be expected because of our seriously flawed 
nature. (Curran, 1995) An example of the differences in these two 
contrasting views in relation to children in research is presented in the 
next section of this paper. Paul Ramsey, Refonnation Protestant, and 
Richard McConnick, Roman Catholic, debate the morality of using 
children as subjects for nontherapeutic research, that is, research that 
will not directly benefit them. 
Ethical models provide a framework for systematic reflection, 
and in the case of moral theology, "the model in view of which one 
understands the Christian life." (Curran, 1985, 12) Traditionally, 
according to moral theologian Charles Curran, there have been three 
ethical models proposed in the literature: teleology, mentioned above 
in relation to Aquinas, deontology, and relationality/responsibility. 
Curran proposes that the relationality/responsibility model be 
considered the primary Catholic Christian ethical model. (Curran, 1985, 
11) The relationality/responsibility ethical model "views the moral life 
primarily in tenns of the person's multiple relationships with God, 
neighbor, world, and self and the subject's actions in this context." 
(Curran, 1985, 12) 
Curran gives several reasons for the primacy of his model over 
teleology, based on the ends and purposes, or deontology, based on law, 
obligation and duty. Curran cites scripture as rationale because, he 
notes, new studies indicate that the primary ethical concept of the Old 
Testament was not the law but the covenant. The New Testament 
emphasizes love, and therefore, is arguably relationally focussed. 
Curran describes the teleological model as open to historicity, 
personalism, and the importance of the subject, but, he argues is not 
primary as a model because "one does not have as much control over 
one's life as this model supposes." (Curran, 1985, 13) 
Curran further explains the relationality/responsibility model in 
May, 1998 19 
terms of its negative understanding, the problem of sin. He describes 
the deontological defInition of sin as an act against the law of God. A 
teleological defInition of sin views the sins as going against God. Yet, 
Curran claims, the scriptures describe sin, beginning with Genesis, in 
terms of our relationship with God, neighbor, the world, and self. So, 
serious (or mortal) sin is not primarily an act against the law of God 
(deontology) or going against the ultimate end (teleology), but a 
breaking of one's fourfold relationship of love with God, neighbor, 
world, and self. 
Virtues refer to the different attitudes and dispositions that 
should be present and direct the way in which that person acts. (Curran, 
1985, 76) The traditional virtues, faith, hope, and charity as well as 
others such as justice and fortitude are understood to affect the person 
in all of his or her multiple relationships. Deepening the relationships, 
claims Curran, with God, neighbor, world and self and the virtues 
which direct these relationships constitute the growth and continual 
conversion of the person. So, a person has opportunity to grow in 
virtue through his or her participation/relational involvement in the 
world. 
Is Nontherapeutic Research on Children Acceptable? 
(Ramsey vs. McCormick) 
Paul Ramsey· and Richard McCormick argued both sides of the 
ethics of children participating in research that might not help them 
directly - in fact, research protocols -that could make them worse. 
McCormick defends his view~using a relationality/responsibility model, 
while Ramsey pursues a deontological approach. McCormick, a 
Roman Catholic, sees the possibilities of transcendence (since 
humankind knows innately the right thing to do via natural law) 
through helping one's neighbor. Ramsey, Reformation Protestant, 
views men and women as fallen, and is less ready than McCormick to 
give people power over the vulnerable because the people are flawed. 
In "Proxy Consent in the Experimental Situation", Richard 
McCormick, moral theologian and teacher of health care ethics, 
presented a view in favor of children participating in research even if 
the research would not directly affect them. His position was argued 
using the relationality/responsibility model. McCormick argued that 
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nontherapeutic research on children is ethically defensible if it involves 
minimal risk and holds the prospect of benefitting children as a group. 
In fact, McConnick believes that children and adults are capable of -
and obligated to - volunteer on behalf of the community. McConnick 
would suggest that children would (if they could) want to do the right 
thing, become better by participation (more virtuous) and participate in 
the good of all humankind. 
McCormick views parents in this case as appropriate surrogates 
for deciding on behalf of their children. In fact, he sees parents as 
capable and entitled to make a substituted judgement, and in keeping 
with his view of the ethical life as relational/virtue based, agreeing to 
have your child participate with the community (assuming minimal 
risk) is a good. McConnick argues that "there are basic values that 
defme our potential as human beings that we ought to choose, support, 
and never directly suppress. [By these] values we can know what 
others would choose (up to a point) because they ought." (McConnick, 
1974,471) 
In response to McCormick's view, Ramsey argued that the end 
never justifies the means and that the ethical principle of respect for the 
person always prevails. He holds that children should never be 
considered eligible for research that will not benefit them and that if 
parents or surrogates consent on the child's behalf to such 
nontherapeutic research, they are breaching their fiduciary duty to the 
child. It is on the basis of the lack of respect for the dignity of the 
person, self-detennination, that Ramsey bases his argument not merely 
the exposure to possible risk that the consent might allow. (National 
Commission, 1977,95) 
In his article, "The Enforcement of Morals: Nontherapeutic 
Research on Children", Ramsey argues that the person offering the 
proxy consent has no right to expose a ward to any risk. He goes 
further, arguing that there must be "complete and infonned consent for 
any and all nontherapeutic research." (Ramsey, 1976, 476) Since 
informed consent is not possible in children, protocols recruiting 
children for nontherapeutic research is unacceptable. Ramsey 
concludes by suggesting that McCormick's relational ethic can never 
outweigh the risk of possible harm and inherent use of children as a 
means to an end that they have not agreed to - and that guardians 
cannot presume to agree to on behalf of their ward. 
May, 1998 21 
Recommendations 2 and 4 
Recommendation #2 of the Commission sets forth general 
conditions applicable to all research involving children. ' The 
recommendation has five main conditions: 1) research must be 
scientifically sound; 2) studies must first be done on animals and adult 
humans, then older children before involvement of infants; 3) risks 
must be minimized by using the safest procedures available with a 
sound research design and by using procedures performed for 
diagnostic or treatment purposes as feasible; 4) researchers must make 
adequate provision to protect the privacy of children and their parents, 
and maintain confidentiality of information; and 5) subjects must be 
~elected in an equitable manner. The sixth condition of the 
recommendation requires that all of the other recommendations' 
conditions within the report be satisfied. (National Commission, 1977, 
3) (See Appendix.) 
Recommendation #4 speaks to therapeutic research or research 
that promises the likelihood of direct benefit to the child-subject but has 
greater than minimal risk. This recommendation states that if there is 
more than minimal risk and direct benefit, the IRB must determine that 
1) the risk is justified by the expected benefit; 2) the risklbenefit ratio 
is as favorable to the subjects as alternatives; 3) consent/assent of 
children and permission/consent by parents is provided for; and 4) 
conditions of recommendation #2 are met. 
In the case study below, I will illustrate ways in which both of 
these recommendations have been violated in the case of the child-
subjects whose parents have consented to their participation in the 
study group. 
Case Study on Duchenne Muscular Dystrophy 
Duchenne Muscular Dystrophy (DMD) is a genetic disease affecting 
boys that makes them unable to produce the protein dystrophin which 
is a necessary component of muscle fiber function. Eventually, the 
repair capacity is exhausted and the muscle dies. In most cases, 
Duchenne forces boys into wheelchairs by the age of ten, due to muscle 
weakness. Since Duchenne Muscular Dystrophy is a progressive 
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disease, it first attacks skeletal muscles in the extremities at age two or 
three, then begins to affect the functioning of brain tissue, and smooth 
muscle like cardiac and bronchial tissue. Often, by early adulthood, 
death occurs as a result of heart or respiratory failure. According to the 
Muscular Dystrophy Association, about 30,000 boys are born with the 
disease annually in the United States. (Thompson, 1992,472) 
Research efforts to cure this disease that affects, and eventually 
kills, children have been the subject of a great deal of attention in the 
past five years. Neuromuscular physiologists and physicians were 
encouraged by the results of cell transplant, a form of gene therapy, on 
animals. Consequently, researchers presented protocols for human 
research on children with DMD to their respective IRBs. 
Protocols for cell transplant or myoblast transfer vary. But 
basically, the process calls for placing several eraser-sized plugs or 
otherwise injected forms of dystrophin-containing tissue into the 
skeletal muscle (upper arms or upper legs) of the child under general 
anesthesia. The children are given immunosuppressive therapy for up 
to six months after the procedure so that they will not reject the 
transplants. In most cases, the children act as their own double blind 
control. That is, one arm or leg is used for actual transplant, the other 
is treated with a placebo control that simulates the actual transplant. 
Theoretically, (and promising in some animal studies) the 
dystrophin from the transplanted myoblast cells will fuse with the 
deficient cells and eventually the amount of dystrophin will increase, 
causing an increase of muscle function which researchers measure by 
muscle strength techniques. However, the results of the published 
studies of myoblast transfer on children with DMD were poor. 
(Mendell, 1995, 832) 
In response to the lack of success of the trials, a group of 25 
muscle researchers called for a moratorium on the continuation of all 
myoblast transfer experiments in humans. The open letter, published 
in Science in the summer of 1992, asserted that the myoblast transfer 
failed to improve clinical status. The letter argued a classic risklbenefit 
rationale for the cessation of such study. Since there was no apparent 
benefit to the subjects, there could be no further support to risk the 
negative effects of general anesthesia or immunosuppression. The 
researchers encouraged further animal studies to work out research 
problems before children with DMD were again used for myoblast 
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transfer research. (Thompson, 1992, 738) 
Since its appearance in Science in 1992, many ethicists and 
researchers have supported the moratorium letter. One of the few who 
disagree with the position of the letter is Peter Law, Ph.D., the 
researcher who has done the pioneering work with myoblast transfer 
and MD children. Law does not want to be confmed by IRBs nor is he 
interested in going back to the lab to refine protocols on animal studies. 
(Thompson, 1992,472) 
One could argue that Dr. Law is interested in research without 
interference, perhaps to the detriment of his patients. Law left the 
University of Tennessee (where he was full professor) and started his 
own foundation in Memphis, the Cell Therapy Research Foundation. 
Law explains that "it took too long for experiments to be cleared by the 
university's IRB and [I] feared the 'excessive review' would unduly 
delay [the] next set of human studies." (Thompson, 1992, 472) 
Because Law's foundation is private, the IRB process is not mandatory. 
However, Law has a peer review board, the members of which he 
refuses to identify. 
In addition to his interest in no external control of his studies, 
critics question his methodology. In fact, there are even allegations of 
deliberately vague or incompletely reported data. (Cho, 1995, 7) 
Amidst the controversy, some cell transfer researchers still plan to 
continue experiments including trials on even younger children using 
potentially toxic enzymes during the myoblast transfer process to boost 
efficacy data. (Cho, 1994, 13) 
This case illustrates perfectly the importance of Belmont Report 
principles and subsequent recommendations. What are the ethical 
issues here? Are any of the recommendations violated by Dr. Law and 
others in this case study? 
Few of the Commission standards are met according to ethicist 
Mildred Cho, Ph.D., University of Pennsylvania. Dr. Cho, whose 
background is in both cell biology and bioethlcs, argues that 
continuation of the trials is unethical for several reasons that relate to 
Recommendations #2 and #4 of the National Commission 
Recommendations. The risklbenefit ratio weighs in on the side of too 
much risk, violating the first condition of recommendation #4. Cho 
states that trials planned using younger children as well as the risk of 
more toxicity render currently proposed protocols unacceptable and in 
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violation of Recommendations #2 (second condition) and #4 (first and 
second conditions). In addition, Cho questions the research because 
children with DMD are not subjected to immunosuppression, general 
anesthesia or multiple injections in the course of their medical 
treatment for the disorder - another violation of the second condition 
of Recommendation #4. (Cho, 1994, 13) 
There is little question among researchers about the importance 
of gene therapy in the cure ofDMD. (Lei den, 1995,871) However, 
Cho and Leiden both contend that the area of gene therapy is in its 
infancy and needs to be scrutinized carefully even if morbid diseases 
are at stake. (Cho, 1995, 7; Leiden, 1995,871) Protocols must meet 
ethical research standards. Cho suggests that myoblast transfer is "too 
premature to be performed on humans." And further, that the research 
should have been done on older children and adults with the disease 
before the younger children were involved. (Cho, 1995, 7) This puts 
the research in violation of Recommendation #2. 
Cho asserts that research protocol guidelines were violated at 
the beginning of any DMD research on children since there are adults 
with DMD surviving, and another population of adults with a similar 
disorder, Becker's muscular dystrophy, who could have been subjects 
for efficacy studies that can be toxic. At least adults could consent to 
the added risk - and are less vulnerable physiologically than children 
to therapies that alter major organs and therefore are less prone to 
toxicity. (Cho, 1994, 14) This assertion suggests that the study design 
was faulty from the start, and in violation of the condition of 
Recommendation #2 requiring scientific soundness and significance. 
The answer to the questions raised about the cell therapy 
research of Dr. Law and others seems clear. The research is too risky 
for children based on the evidence that has been collected by the 
research studies done on children with DMD in the past five years. 
Some would say the original design and methodology is ethically 
questionable as well. The protocol is probably of little or no direct 
benefit based on study results to date. In fact, the research may be too 
risky for humans, or at least for young humans, until the toxicity issues 
have been resolved either in the lab or by conducting very carefully 
controlled human studies, possible with Becker's MD patients. 
Recommendations #2 and #4 have clearly been violated by this 
protocol. But what are the underlying principles that support no more 
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research? Certainly the Belmont Report principles: respect for 
vulnerable populations (persons), beneficence and justice all are key 
elements in this case. But the principle that is violated most clearly, it 
seems to the author, is beneficence (obligation to "do no harm" and 
minimize risk and maximize benefit). (National Commission, 1978, 6) 
It appears it was unnecessary to use this particular group of MD 
patients for the initial testing, premature to begin testing humans at all, 
and questionable to consider risking anesthesia and immunosuppression 
at this early stage of study. All of these threatened to harm the child-
subjects and did not adequately seem to minimize risk to the subjects. 
Summary 
This research paper began asking the wisdom of research for 
children if there is some risk involved in the trial, the government's 
role, and the theological viewpoint regarding ethical guidelines. The 
guidelines developed for child-subjects based on the ethical principles 
of the Belmont Report support the participation of children in research 
protocols - even with some risk - as long as the research is of direct 
benefit. Nontherapeutic research and research with more than minimal 
risk, as we have seen, require more protection - and specific conditions. 
Children are protected but parents/guardians and researchers are given 
important roles in deciding risk and consenting on behalf of the child. 
So, the adults must ultimately act in a way that will protect the 
vulnerable. 
One could argue, I think, that a more "Catholic" view of 
humankind, using a framework that relied on the parents and 
researchers to act responsibly, undergirded some of the Commission's 
work. The ambiguity of definitions like minimal risk was, by the 
Commission's own admission, intended to put the onus on the 
accountability of the adults involved in the research milieu. The 
Commission states that the "ultimate children's right is the obligation 
that adults have to protect and nurture children. It is the role of adults 
to ensure that children are not subjected to unnecessary or excessive 
risks or discomfort. Such protection can only come from adults who 
control research with children ... " (National Commission, 1977, 128) 
The Commission, to their credit, called on the community to "do the 
good." 
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Appendix 
Recommendations of the National Commission for the 
Protection of Human Subjects of Biomedical and Behavioral 
Research 
Recommendation (1) 
Since the Commission finds that research involving children is 
important for the health and well-being of all children and can be 
conducted in an ethical manner, the Commission recommends that such 
research be conducted and supported, subject to the conditions set forth 
in the following recommendations. 
Recommendation (2) 
Research involving children may be conducted or supported provided 
an Institutional Review Board has determined that (A) the research is 
scientifically sound and significant; (B) where appropriate, studies have 
been conducted first on animals and adult humans, then on older 
children, prior to involving infants; (C) risks are minimized by using 
the safest procedures consistent with sound research design and by 
using procedures performed for diagnostic or treatment purposes 
whenever feasible; (D) adequate provisions are made to protect the 
privacy of children and their parents, and to maintain confidentiality of 
data; (E) subjects will be selected in an equitable manner; and (F) the 
conditions of all applicable subsequent recommendations are met. 
Recommendation (3) 
Research that does not involve greater than minimal risk to children 
may be conducted or supported provided an Institutional Review Board 
has determined that: (A) the conditions of Recommendation (2) are 
met; and (B) adequate provisions are made for assent of the children 
and pennission of their parents or guardians, as set forth in 
Recommendations (7) and (8). 
Recommendation (4) 
Research in which more than minimal risk to children is presented by 
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an intervention that holds out the prospect of direct benefit for the 
individual subjects, or by a monitoring procedure required for the well-
being of the subjects, may be conducted or supported provided an 
Institutional Review Board has determined that: 
(A) Such risk is justified by the anticipated benefit to the 
subjects; 
(B) The relation of anticipated benefit to such risk is at least as 
favorable to the subjects as that presented by available 
alternative approaches; 
(C) The conditions of Recommendation (2) are met; and 
(D) Adequate provisions are made for assent of the children and 
permission of their parents or guardians, as set forth in 
Recommendations (7) and (8). 
Recommendation (5) 
Research in which more than minimal risk to children is presented by 
an intervention that does not hold out the prospect of direct benefit for 
the individual subjects, or by a monitoring procedure not required for 
the well-being of the subjects, may be conducted or supported provided 
an Institutional Review Board has determined that: 
(A) Such risk represents a minor increase over minimal risk; 
(B) Such intervention or procedure presents experiences to 
subjects that are reasonably commensurate with those inherent 
in their actual or expected medical, psychological or 'social 
situations, and is likely to yield generalizable knowledge about 
the subjects' disorder or condition; 
(C) The anticipated knowledge is of vital importance for 
understanding or amelioration of the subjects' disorder or 
condition; 
(D) The conditions of Recommendation (2) are met; and 
(E) Adequate provisions are made for assent of the children and 
permission of their parents or guardians, as set forth in 
Recommendations (7) and (8). 
Recommendation (6) 
Research that cannot be approved by an Institutional Review Board 
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under Recommendations (3), (4), and (5), as applicable, may be 
conducted or supported provided an Institutional Review Board has 
determined that the research presents an opportunity to understand, 
prevent, or alleviate a serious problem affecting the health or welfare 
of children and, in addition, a national ethical advisory board and, 
following opportunity for public review and comment, the secretary of 
the responsible federal department (or highest official of the responsible 
federal agency) have determined either (A) that the research satisfies 
the conditions of Recommendations (3), (4), and (5), as applicable, or 
(B) the following: 
(I) The research presents an opportunity to understand, prevent, 
or alleviate a serious problem affecting the health or welfare of 
children; 
(ll) The conduct of the research would not violate the principles 
of respect for persons, beneficence and justice; 
(III) The conditions of Recommendation (2) are met; and 
(IV) Adequate provisions are made for assent of the children 
and permission of their parents or guardians, as set forth in 
Recommendations (7) and (8). 
Recommendation (7) 
In addition to the determinations required under the foregoing 
recommendations, as applicable, the Institutional Review Board should 
determine that adequate provisions are made for: (A) soliciting the 
assent of the children (when capable) and the permission of their 
parents or guardians; and, when appropriate, (B) monitoring the 
solicitation of assent and permission, and involving at least one parent 
or guardian in the conduct of the research. A child's objection to 
participation in research should be binding unless the intervention holds 
out a prospect of direct benefit that is important to the health or well-
being of the child and is available only in the context of the research. 
Recommendation (8) 
If the Institutional Review Board determines that a research protocol is 
designed for conditions or a subject population for which parental or 
guardian permission is not a reasonable requirement to protect the 
subjects, it may waive such requirement provided an appropriate 
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mechanism for protecting the children who will participate as subjects 
in the research is substituted. The choice of an appropriate mechanism 
should depend upon the nature and purpose of the activities described 
in the protocol, the risk and anticipated benefit to the research subjects, 
and their age, status and condition. 
Recommendation (9) 
Children who are wards of the state should not be included in research 
approved under Recommendations (5) or (6) unless such research is: 
(A) related to their status as orphans, abandoned children, and the like; 
or (B) conducted in a school or similar group setting in which the 
majority of children involved as subjects are not wards of the state. If 
such research is approved, the Institutional Review Board should 
require that an advocate for each child be appointed, with an 
opportunity to intercede that would normally be provided by parents. 
Recommendation (10) 
Children who reside in institutions for the mentally infirm or who are 
confmed in correctional facilities should participate in research only if 
the conditions regarding research on the institutionalized mentally 
infirm or on prisoners (as applicable) are fulfilled in addition to the 
conditions set forth herein. 
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